Eric Yang has extensive experience in the pharmaceutical industry, having served as Vice President at GSK from July 2010 to January 2024, where leadership encompassed biomarker and bioanalytical platforms, immunogenicity, and bioanalytical sciences. Yang developed global teams to advance expertise in various analytical techniques, including Immunoassay, Flow Cytometry, Genomics, and LC/MS, with a focus on enabling pharmacokinetic modeling and biomarker development across a diverse portfolio in areas such as Oncology and Infectious Diseases. Prior to GSK, Yang completed postdoctoral research at Cornell University and earned a PhD in Chemistry from The University of Georgia, where innovative analytical methods for glycoprotein analysis were developed.
This person is not in the org chart
This person is not in any teams
This person is not in any offices